Foley Partner Judith Waltz authored an article that appeared in the August 2010 edition of Medical Device and Diagnostic Industry titled “U.S. Focuses Enforcement on Manufacturers.” Waltz discusses increasing healthcare enforcement activity under the Obama administration, stating that the federal government has focused enforcement activity on how providers are billing products to government healthcare programs. She recommends that manufacturers review recent False Claims Act settlements and consider whether further scrutiny of their product support services and pricing strategies may be warranted.
Click here to read the complete article.
Author(s)
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.